Published in J Oncol on February 15, 2012
Advanced endoscopic ultrasound management techniques for preneoplastic pancreatic cystic lesions. J Investig Med (2016) 0.75
SW43-DOX ± loading onto drug-eluting bead, a potential new targeted drug delivery platform for systemic and locoregional cancer treatment - An in vitro evaluation. Mol Oncol (2016) 0.75
Making the Case: Intra-arterial Therapy for Less Common Metastases. Semin Intervent Radiol (2017) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol (1997) 29.02
Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis (2010) 9.73
Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. J Clin Oncol (2009) 5.11
Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol (2009) 4.82
Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma. J Clin Oncol (2003) 4.56
DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol (2006) 2.33
Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas. Invest New Drugs (1994) 2.33
A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin Gastroenterol Hepatol (2007) 2.06
A late phase II study of S-1 for metastatic pancreatic cancer. Cancer Chemother Pharmacol (2007) 1.59
Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol (2007) 1.59
Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J Vasc Interv Radiol (2006) 1.53
Registries that show efficacy: good, but not good enough. J Clin Oncol (2008) 1.25
Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results. J Vasc Interv Radiol (2008) 1.17
Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study. Ann Surg Oncol (2010) 1.16
Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report. World J Surg Oncol (2009) 1.16
Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry. Cardiovasc Intervent Radiol (2010) 1.07
Brief communication: a new combination in the treatment of advanced pancreatic cancer. Semin Oncol (2005) 1.03
Treatment response to transcatheter arterial embolization and chemoembolization in primary and metastatic tumors of the liver. HPB (Oxford) (2008) 0.96
Five-year survival of metastatic pancreatic carcinoma: a study of courage and hope. Gastrointest Cancer Res (2009) 0.95
One year survival with poorly differentiated metastatic pancreatic carcinoma following chemoembolization with gemcitabine and cisplatin. Oncol Rep (2010) 0.80
Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches. Ann Surg (2008) 2.80
Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol (2004) 2.18
Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study. J Gastrointest Surg (2014) 2.15
Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol (2012) 1.99
Management of hepatic metastasis of gastrointestinal carcinoid tumors. J Surg Oncol (2008) 1.88
Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. J Clin Oncol (2006) 1.85
A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate? J Am Coll Surg (2010) 1.83
Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer. J Am Coll Surg (2004) 1.58
Nutritional management during neoadjuvant therapy for esophageal cancer. J Surg Oncol (2009) 1.54
Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy? Cancer (2010) 1.53
Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations. Cardiovasc Intervent Radiol (2011) 1.48
Assessment of mitotic rate reporting in melanoma. Am J Surg (2012) 1.47
The lower incidence of melanoma in women may be related to increased preventative behaviors. Am J Surg (2010) 1.45
Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann Surg (2014) 1.44
Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol (2009) 1.44
An evaluation of 2537 gastrointestinal stromal tumors for a proposed clinical staging system. Arch Surg (2009) 1.42
Acceptance of sentinel lymph node biopsy of the breast by all general surgeons in kentucky. Breast J (2005) 1.41
Factors associated with surgical options for breast carcinoma. Cancer (2006) 1.34
Hepatic tumor ablation with clustered microwave antennae: the US Phase II trial. HPB (Oxford) (2007) 1.33
Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated. PLoS One (2013) 1.32
Gender-related differences in outcome for melanoma patients. Ann Surg (2006) 1.32
Lumpectomy margins are affected by tumor size and histologic subtype but not by biopsy technique. Am J Surg (2004) 1.25
HIV transmission in a state prison system, 1988-2005. PLoS One (2009) 1.24
Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases. Ann Surg Oncol (2008) 1.20
Surgical management of pulmonary carcinoid tumors: sublobar resection versus lobectomy. Am J Surg (2012) 1.20
Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent? J Gastrointest Surg (2008) 1.18
Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study. Ann Surg Oncol (2010) 1.16
Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report. World J Surg Oncol (2009) 1.16
Laparoscopic left pancreatectomy: complication risk score correlates with morbidity and risk for pancreatic fistula. Ann Surg Oncol (2009) 1.10
A proposed staging system for rectal carcinoid tumors based on an analysis of 4701 patients. Surgery (2008) 1.08
Factors associated with false-negative sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol (2009) 1.08
Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry. Cardiovasc Intervent Radiol (2010) 1.07
Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy. J Surg Res (2009) 1.06
A statin-regulated microRNA represses human c-Myc expression and function. EMBO Mol Med (2012) 1.03
Stroke volume variation in hepatic resection: a replacement for standard central venous pressure monitoring. Ann Surg Oncol (2013) 1.02
Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry. J Oncol (2009) 1.01
Reflux injury of esophageal mucosa: experimental studies in animal models of esophagitis, Barrett's esophagus and esophageal adenocarcinoma. Dis Esophagus (2007) 1.01
Popliteal lymph node dissection. Ann Surg Oncol (2005) 1.00
Laparoscopic versus open resection of hepatic colorectal metastases. Surgery (2012) 1.00
Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis? J Am Coll Surg (2009) 0.99
Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis. J Am Coll Surg (2011) 0.99
Financial comparison of laparoscopic versus open hepatic resection using deviation-based cost modeling. Ann Surg Oncol (2013) 0.98
Predicting patients at low probability of requiring postmastectomy radiation therapy. Ann Surg Oncol (2006) 0.98
Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection. HPB (Oxford) (2012) 0.98
Factors associated with recurrence and survival following hepatectomy for large hepatocellular carcinoma: a multicenter analysis. J Surg Oncol (2010) 0.98
A proposed staging system for small bowel carcinoid tumors based on an analysis of 6,380 patients. Am J Surg (2008) 0.98
The evolving importance of readmission data to the practicing surgeon. J Am Coll Surg (2010) 0.97
Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study. HPB (Oxford) (2010) 0.97
Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma. Ann Surg (2010) 0.96
Chemoprotective effects of Curcuma aromatica on esophageal carcinogenesis. Ann Surg Oncol (2008) 0.96
Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits? J Am Coll Surg (2009) 0.94
Prognostic significance of tumor infiltrating lymphocytes in melanoma. Am Surg (2011) 0.92
Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett esophagus. Arch Surg (2005) 0.92
Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett's esophagus to adenocarcinoma. World J Gastroenterol (2006) 0.92
Second primary melanomas: incidence and outcome. Am Surg (2010) 0.92
Herbal medicine and hepatocellular carcinoma: applications and challenges. Evid Based Complement Alternat Med (2011) 0.92
Sentinel lymph node biopsy in patients with ductal carcinoma in situ: a proposal. Cancer (2002) 0.91
Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker. Am J Surg (2011) 0.90
Factors determining adequacy of axillary node dissection in breast cancer patients. Breast J (2007) 0.90
Anemia and transfusions in patients undergoing surgery for cancer. Ann Surg Oncol (2007) 0.89
Overall survival peri-hilar cholangiocarcinoma: R1 resection with curative intent compared to primary endoscopic therapy. J Surg Oncol (2011) 0.89
The prognostic significance of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol (2010) 0.88
Optimal abdominal incision for partial hepatectomy: increased late complications with Mercedes-type incisions compared to extended right subcostal incisions. World J Surg (2006) 0.88
Proposed staging system for colon carcinoid tumors based on an analysis of 2,459 patients. J Am Coll Surg (2008) 0.88
recurrence following hepatectomy for metastatic colorectal cancer: development of a model that predicts patterns of recurrence and survival. Ann Surg Oncol (2011) 0.87
A proposed staging system for gastric carcinoid tumors based on an analysis of 1,543 patients. Ann Surg Oncol (2008) 0.87
Hepatic malignant epithelioid hemangioendothelioma: a case report and review of the literature. Am Surg (2008) 0.87
Hepatic resection for colorectal liver metastases. Surg Clin North Am (2010) 0.87
Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival. Ann Surg Oncol (2010) 0.87
Are 3 sentinel nodes sufficient? Arch Surg (2007) 0.86
Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma. Am Surg (2011) 0.86
Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor. J Am Coll Surg (2013) 0.86
Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial. J Gastrointest Surg (2012) 0.86
Loss of manganese superoxide dismutase expression and activity in rat esophagus with external esophageal perfusion. Surgery (2007) 0.86
Hepatic imaging characteristics predict overall survival in hepatocellular carcinoma. Ann Surg Oncol (2007) 0.86
Lymphovascular invasion as a prognostic factor in melanoma. Am Surg (2011) 0.86
Optimal technique and response of doxorubicin beads in hepatocellular cancer: bead size and dose. Korean J Hepatol (2011) 0.85
Hepatic arterial infusion of doxorubicin-loaded microsphere for treatment of hepatocellular cancer: a multi-institutional registry. J Am Coll Surg (2011) 0.85
Analysis of 900 appendiceal carcinoid tumors for a proposed predictive staging system. Arch Surg (2008) 0.85
Does mitotic rate predict sentinel lymph node metastasis or survival in patients with intermediate and thick melanoma? Am J Surg (2010) 0.85
Alterations in manganese superoxide dismutase expression in the progression from reflux esophagitis to esophageal adenocarcinoma. Ann Surg Oncol (2007) 0.85
Hepatic tumor ablation: cryo versus radiofrequency, which is better? Am Surg (2006) 0.84
Body mass index influences palpability but not stage of breast cancer at diagnosis. Am Surg (2007) 0.84
Hepatectomy is superior to thermal ablation for patients with a solitary colorectal liver metastasis. J Gastrointest Surg (2010) 0.84
Effect of multiple-nodal basin drainage on cutaneous melanoma. Arch Surg (2008) 0.84
Low-energy DC current ablation in a mouse tumor model. Methods Mol Biol (2014) 0.84
Phase II comparison study of intraoperative autotransfusion for major oncologic procedures. Ann Surg Oncol (2011) 0.84
A prospective phase II evaluation of esophageal stenting for neoadjuvant therapy for esophageal cancer: optimal performance and surgical safety. J Am Coll Surg (2011) 0.84